The U.S. has registered over half a million clinical trials since 2000. Here's a look at the business and ethics of human ...

A field-effect transistor biosensor (left) for measuring antibody levels and a microneedle patch on top of a penny. Combining a microneedle patch (right) with a field-effect transistor biosensor for ...

Research led by the University of Washington reports on an AI-guided method that designs epitope-specific antibodies and confirms atomically precise binding using high-resolution molecular imaging, ...

In therapeutic antibody development the fragment crystallizable (Fc) region is far more than just an antigen-binding aid; it's role is much larger, functioning as the antibody’s functional control ...

The FDA on Friday revoked the emergency use authorizations (EUAs) of four monoclonal antibodies for COVID-19. The four drugs -- bebtelovimab, sotrovimab, casirivimab ...

Moderna Inc. (NASDAQ:MRNA) on Tuesday released preliminary immunogenicity data for the 2025-2026 formula of mNEXSPIKE (COVID-19 Vaccine, mRNA), which targets the LP.8.1 variant of SARS-CoV-2. The data ...

Moderna has early in-human data showing its next-generation COVID-19 vaccine, mNEXSPIKE, has the potential to offer strong immune protection against the latest rapidly spreading SARS-CoV-2 virus.

Some people vaccinated against COVID-19 initially acquire strong levels of neutralizing antibodies but then experience rapid declines. Measuring immunoglobulin A antibody titers post-vaccination could ...

Pfizer Inc. (NYSE:PFE) and BioNTech SE (NASDAQ:BNTX) reported topline Phase 3 results for their LP.8.1-adapted monovalent COMIRNATY (2025-2026 Formula) in high-risk adults. Among 100 participants, the ...

Laura holds a Master's in Experimental Neuroscience and a Bachelor's in Biology from Imperial College London. Her areas of expertise include health, medicine, psychology, and neuroscience. Laura holds ...

Invivyd (NASDAQ:IVVD) received guidance from the U.S. Food and Drug Administration and is aligned with a streamlined, expedited pathway toward potential biologics license application approval for its ...

A new COVID-19 variant that was unheard of just months ago is now projected to be the second-most common strain in the United States. Variant NB.1.8.1 was first detected in China in January but ...